Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1984 1
1999 1
2010 1
2011 2
2012 2
2013 3
2014 2
2015 7
2016 1
2017 3
2019 3
2020 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

27 results
Results by year
Filters applied: . Clear all
Page 1
Lipoprotein apheresis--more than just cholesterol reduction?
Neumann CL, Schulz EG, Hagenah GC, Platzer U, Wieland E, Schettler V. Neumann CL, et al. Atheroscler Suppl. 2013 Jan;14(1):29-32. doi: 10.1016/j.atherosclerosissup.2012.10.017. Atheroscler Suppl. 2013. PMID: 23357137 Review.
Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels.
Schettler VJJ, Neumann CL, Peter C, Zimmermann T, Julius U, Hohenstein B, Roeseler E, Heigl F, Grützmacher P, Blume H, Klingel R, Vogt A; Scientific Board of GLAR for the German Apheresis Working Group. Schettler VJJ, et al. Among authors: neumann cl. Clin Res Cardiol Suppl. 2019 Apr;14(Suppl 1):33-38. doi: 10.1007/s11789-019-00094-4. Clin Res Cardiol Suppl. 2019. PMID: 30838552
The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the future.
Omboni S, Padwal RS, Alessa T, Benczúr B, Green BB, Hubbard I, Kario K, Khan NA, Konradi A, Logan AG, Lu Y, Mars M, McManus RJ, Melville S, Neumann CL, Parati G, Renna NF, Ryvlin P, Saner H, Schutte AE, Wang J. Omboni S, et al. Among authors: neumann cl. Connect Health. 2022 Jan 4;1:7-35. doi: 10.20517/ch.2021.03. Connect Health. 2022. PMID: 35233563 Free PMC article.
27 results